These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 12370767

  • 1. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
    Boltze C, Roessner A, Landt O, Szibor R, Peters B, Schneider-Stock R.
    Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
    [Abstract] [Full Text] [Related]

  • 2. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F, Morari J, Morari EC, Correa LA, Assumpção LV, Ward LS.
    Cancer Lett; 2004 Jul 16; 210(2):151-7. PubMed ID: 15183530
    [Abstract] [Full Text] [Related]

  • 3. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC.
    Cancer Epidemiol Biomarkers Prev; 2000 Oct 16; 9(10):1037-42. PubMed ID: 11045785
    [Abstract] [Full Text] [Related]

  • 4. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
    Malisic E, Jankovic R, Slavkovic D, Milovic-Kovacevic M, Radulovic S.
    J BUON; 2010 Oct 16; 15(1):101-6. PubMed ID: 20414935
    [Abstract] [Full Text] [Related]

  • 5. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
    Lai KC, Chen WC, Tsai FJ, Li SY, Jeng LB.
    Hepatogastroenterology; 2005 Oct 16; 52(63):944-8. PubMed ID: 15966238
    [Abstract] [Full Text] [Related]

  • 6. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
    Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, Kang SB, Lee HP.
    Gynecol Oncol; 2004 May 16; 93(2):499-505. PubMed ID: 15099969
    [Abstract] [Full Text] [Related]

  • 7. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM, Shun CT, Wu MT, Chen YY, Yang SY, Hung HI, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC.
    Mutat Res; 2006 Feb 22; 594(1-2):181-8. PubMed ID: 16318864
    [Abstract] [Full Text] [Related]

  • 8. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B, Toumi N, Khabir A, Sellami-Boudawara T, Ghorbel A, Daoud J, Frikha M, Gargouri A, Mokdad-Gargouri R.
    Cancer Genet Cytogenet; 2007 Oct 15; 178(2):89-93. PubMed ID: 17954263
    [Abstract] [Full Text] [Related]

  • 9. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.
    Bonafé M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, Invidia L, Vannini I, Rossi M, Marzi E, Mishto M, Capri M, Olivieri F, Antonicelli R, Memo M, Uberti D, Nacmias B, Sorbi S, Monti D, Franceschi C.
    Cell Death Differ; 2004 Sep 15; 11(9):962-73. PubMed ID: 15131588
    [Abstract] [Full Text] [Related]

  • 10. p53 analysis of laryngeal cancer in exon 4 to 9.
    Gottschlich S, Maune S, Preugschat J, Hoffmann M, Werner JA, Maass JD, Görögh T, Heidorn K, Rudert H.
    Anticancer Res; 2000 Sep 15; 20(4):2613-6. PubMed ID: 10953333
    [Abstract] [Full Text] [Related]

  • 11. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y, McDermott MP, Ahrendt SA.
    Clin Cancer Res; 2005 Apr 01; 11(7):2502-9. PubMed ID: 15814626
    [Abstract] [Full Text] [Related]

  • 12. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
    Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, Farthing MJ, Alderson D, Holly J.
    Clin Cancer Res; 2003 Jun 01; 9(6):2151-6. PubMed ID: 12796380
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population.
    Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T.
    J Soc Gynecol Investig; 2004 May 01; 11(4):232-6. PubMed ID: 15120697
    [Abstract] [Full Text] [Related]

  • 15. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
    Suárez-Rincón AE, Morán-Moguel MC, Montoya-Fuentes H, Gallegos-Arreola MP, Sánchez-Corona J.
    Ginecol Obstet Mex; 2002 Jul 01; 70():344-8. PubMed ID: 12221910
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-Prado JC, Reis PM, de Freitas SE, Filho JF, Fukuyama EE, Cordeiro JA, Cury PM, Maniglia JV, Villa LL, Tajara EH, Rahal P.
    Cancer Genet Cytogenet; 2004 Apr 01; 150(1):44-9. PubMed ID: 15041222
    [Abstract] [Full Text] [Related]

  • 18. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, Slomski R.
    Oncol Rep; 2006 Jul 01; 16(1):65-71. PubMed ID: 16786124
    [Abstract] [Full Text] [Related]

  • 19. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP, Frazzon AP, Damin DC, Roehe A, Hermes V, Zettler C, Alexandre CO.
    Cancer Detect Prev; 2006 Jul 01; 30(6):523-9. PubMed ID: 17113725
    [Abstract] [Full Text] [Related]

  • 20. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.
    Cancer Lett; 2004 Jul 16; 210(2):197-203. PubMed ID: 15183535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.